Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Depreciation & Amortization (CF) (2020 - 2025)

Bio Essence has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $59.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 1.72% year-over-year to $59.0; the TTM value through Dec 2025 reached $235.0, down 74.2%, while the annual FY2025 figure was $235.0, 74.2% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $59.0 at Bio Essence, up from $58.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $15291.0 in Q3 2022 and troughed at -$23155.0 in Q4 2022.
  • A 5-year average of $2812.7 and a median of $1412.0 in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 336.28% in 2022 and later soared 102.38% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $9800.0 in 2021, then tumbled by 336.28% to -$23155.0 in 2022, then soared by 89.45% to -$2442.0 in 2023, then soared by 102.38% to $58.0 in 2024, then grew by 1.72% to $59.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for BIOE at $59.0 in Q4 2025, $58.0 in Q3 2025, and $59.0 in Q2 2025.